$AVXL $0.47 choppy / higher lows. 10-Q 2/1
Post# of 63700
10-Q 2/14/14
O/S 37,640,098
- Anavex Strengthens Alzheimer's Pipeline, Obtains Exclusive Worldwide Rights to Intellectual Property
3/31/2014 7:33:00 AM - GlobeNewswire - Anavex Reports Predicted Clinical Effect of Both ANAVEX 2-73 and ANAVEX PLUS in a Humanized Cortical Cognitive Model for Alzheimer's Disease
3/27/2014 12:59:00 PM - GlobeNewswire - Anavex Successfully Closes $10 Million Financing to Initiate Phase 1b/2a Alzheimer's Clinical Trial
3/19/2014 7:37:00 AM - GlobeNewswire - Anavex Announces $10 Million Private Placement of Convertible Debentures
3/13/2014 10:35:00 AM - GlobeNewswire - Anavex Encouraged By Scientific Data Confirming Sigma-1 Receptor Agonist Extends Survival in ALS (Lou Gehrig's Disease)
3/10/2014 7:33:00 AM - GlobeNewswire